Apellis Pharmaceuticals Inc (APLS)
58.47
-0.53
(-0.90%)
USD |
NASDAQ |
Mar 27, 16:00
58.48
+0.01
(+0.02%)
After-Hours: 20:00
Apellis Pharmaceuticals Shares Outstanding: 120.58M for Feb. 20, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 20, 2024 | 120.58M |
December 31, 2023 | 119.56M |
October 24, 2023 | 118.50M |
September 30, 2023 | 118.36M |
July 24, 2023 | 117.74M |
June 30, 2023 | 117.58M |
May 01, 2023 | 116.46M |
April 03, 2023 | 116.18M |
March 31, 2023 | 116.18M |
February 27, 2023 | 115.30M |
February 15, 2023 | 111.29M |
December 31, 2022 | 110.77M |
November 01, 2022 | 110.58M |
September 30, 2022 | 110.48M |
August 04, 2022 | 109.87M |
August 01, 2022 | 108.86M |
June 30, 2022 | 106.84M |
April 29, 2022 | 106.52M |
April 05, 2022 | 106.47M |
March 31, 2022 | 106.44M |
March 28, 2022 | 106.30M |
February 23, 2022 | 97.73M |
December 31, 2021 | 97.52M |
November 18, 2021 | 97.36M |
November 02, 2021 | 87.30M |
Date | Value |
---|---|
September 30, 2021 | 87.22M |
August 03, 2021 | 87.00M |
July 23, 2021 | 86.49M |
June 30, 2021 | 80.96M |
April 23, 2021 | 80.50M |
April 05, 2021 | 80.44M |
March 31, 2021 | 80.44M |
February 22, 2021 | 80.38M |
January 26, 2021 | 79.64M |
December 31, 2020 | 76.13M |
October 28, 2020 | 75.74M |
September 30, 2020 | 75.70M |
July 27, 2020 | 75.60M |
June 30, 2020 | 75.60M |
April 24, 2020 | 75.51M |
April 13, 2020 | 75.50M |
March 31, 2020 | 75.40M |
February 21, 2020 | 75.32M |
January 13, 2020 | 74.86M |
December 31, 2019 | 63.94M |
November 01, 2019 | 63.89M |
September 30, 2019 | 63.87M |
August 31, 2019 | 63.81M |
July 24, 2019 | 63.70M |
June 30, 2019 | 63.67M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
63.22M
Minimum
Mar 31 2019
120.58M
Maximum
Feb 20 2024
90.98M
Average
87.00M
Median
Aug 03 2021
Shares Outstanding Benchmarks
Blueprint Medicines Corp | 61.23M |
Alnylam Pharmaceuticals Inc | 125.95M |
Ionis Pharmaceuticals Inc | 145.75M |
Madrigal Pharmaceuticals Inc | 19.90M |
Sarepta Therapeutics Inc | 93.86M |